Invivyd, Inc. (IVVD) stock
IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3048% below fair value
$0.51−0.03 (-4.67%)
Close on Nov 17, 2026Market cap $151.09MP/E –Yield –
Invivyd price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Invivyd's price to book ratio was 1.0× on Nov 11, 2026, against 5.6× a year earlier. Over the last 5 years it ranged from 0.3× to 5.7×, with a median of 1.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.0× | −4.7 |
| 2025 | Dec 31, 2025 | 5.7× | +5.1 |
| 2024 | Dec 31, 2024 | 0.6× | −1.1 |
| 2023 | Dec 29, 2023 | 1.8× | +1.3 |
| 2022 | Dec 30, 2022 | 0.4× | −0.8 |
| 2021 | Dec 31, 2021 | 1.3× | – |
See a number that looks wrong?